Topigen Pharmaceuticals Inc. Appoints Jeremy Curnock Cook to Its Board of Directors

Published: Jun 03, 2008

MONTREAL--(Marketwire - June 03, 2008) - TOPIGEN Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specialized in developing products for respiratory disorders, today announced the appointment of Jeremy Curnock Cook, MA, to its Board of Directors. Mr. Curnock Cook is Executive Chairman and founder of BioScience Managers Limited (BML).

Back to news